Detection of donor-derived cell-free DNA in the setting of multiple kidney transplantations
BackgroundThe routine use of donor-derived cell-free DNA (dd-cfDNA) assays to monitor graft damage in patients after kidney transplantation is being implemented in many transplant centers worldwide. The interpretation of the results can be complicated in the setting of multiple sequential kidney tra...
Main Authors: | Linnea Pettersson, Lukas Frischknecht, Sofia Westerling, Hamid Ramezanali, Lukas Weidmann, Kai Castrezana Lopez, Thomas Schachtner, Jakob Nilsson |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2024-02-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2024.1282521/full |
Similar Items
-
Donor-Derived Cell-Free DNA in Kidney Transplantation as a Potential Rejection Biomarker: A Systematic Literature Review
by: Adrian Martuszewski, et al.
Published: (2021-01-01) -
Assessment of Donor Derived Cell Free DNA (dd-cfDNA) at Surveillance and at Clinical Suspicion of Acute Rejection in Renal Transplantation
by: Evangelos Mantios, et al.
Published: (2023-10-01) -
Donor-Derived Cell-Free DNA at 1 Month after Kidney Transplantation Relates to HLA Class II Eplet Mismatch Load
by: Elena González-López, et al.
Published: (2023-10-01) -
Donor-Derived Cell-Free DNA (dd-cfDNA) in Kidney Transplant Recipients With Indication Biopsy—Results of a Prospective Single-Center Trial
by: Louise Benning, et al.
Published: (2023-11-01) -
Donor-Derived Cell-Free DNA as a Non-Invasive Biomarker for Graft Rejection in Kidney Transplant Recipients: A Prospective Study among the Indian Population
by: Naveen Kumar, et al.
Published: (2023-11-01)